Back

Left ventricular reverse remodeling in heart failure with reduced ejection fraction: determinants and outcomes in a multidisciplinary heart failure clinic in a resource limited setting

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Cardiac remodeling across the ejection fraction spectrum Ventricular Remodelling HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Bui Khiong Chung

Sarawak Heart Center, Kuching (Malaysia)

4 More presentations in this session

Presentation thumbnail
EPA:DHA 6:1 prevents right ventricular dysfunction and lung vascular remodeling in monocrotaline-induced pulmonary arterial hypertension in rats by mitigating inflammatory and pro-oxidant responses
Doctor S. AMISSI (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Echocardiographic parameters in patients with right heart failure and sarcopenia.
Doctor M. Hernandez Hernandez (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
Cardiac reverse remodeling after SGLT2 inhibitor therapy: exploring beyond sex differences
Doctor S. Prosperi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Multiparametric approach to predict long-term survival in ischemic heart failure patients undergoing surgical ventricular reconstruction
Doctor G. Guida (San Donato Milanese, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac remodeling across the ejection fraction spectrum

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Predictors of early left ventricular reverse remodelling and prognosis in new-onset heart failure of non-ischemic origin
thumbnail
Congress Presentation
The impact of left ventricular reverse remodeling on asymptomatic structual heart disease
thumbnail
Congress Presentation
Cardiac reverse remodeling induced by cardiac resynchronization therapy results in distinct changes in myocardial work when compared to guideline directed medical therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources